{
  "kind": "all",
  "value": "all",
  "collectionKey": "slides:all:all:all-document-kinds:all-producers:all-orientations",
  "filters": {
    "documentKinds": [],
    "sourceTypes": [],
    "orientations": []
  },
  "total": 319975,
  "page": 7692,
  "pageSize": 30,
  "pageCount": 10666,
  "rows": [
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 26,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The diagram shows a summation of two patient groups (prevalence and incidence-derived relapsed/refractory) to reach a total eligible patient count.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/26",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-26",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 27,
      "slideType": "unfair_advantage",
      "function": "present_solution",
      "notes": "The slide uses a molecular biology diagram to illustrate structural differences in binding domains and intracellular signaling components.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/27",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-27",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 28,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a visual comparison of three treatment timelines to highlight the superior safety profile of NXC-201.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/28",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-28",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 29,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The table compares NXC-201 against Darzalex, CAEL-101, and Birtamimab across various clinical metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/29",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-29",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 30,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "Uses a before-and-after framing to illustrate market expansion potential.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/30",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-30",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 31,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a structural layout to map platform capabilities to specific therapeutic products.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/31",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-31",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 32,
      "slideType": "roadmap",
      "function": "show_traction",
      "notes": "The slide uses a step-diagram to illustrate dose escalation.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/32",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-32",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 33,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a process diagram illustrating the medical procedure and a list of key attributes.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/33",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-33",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 34,
      "slideType": "why_now",
      "function": "argue_timing",
      "notes": "Includes a comparative table of clinical outcomes (ORR, CR/sCR) for NXC-201 vs competitors.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/34",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-34",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 35,
      "slideType": "appendix_data",
      "function": "analyze_data",
      "notes": "The table highlights low incidence of severe adverse events and management protocols for NXC-201.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/35",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-35",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 36,
      "slideType": "peer_benchmark",
      "function": "compare_peers",
      "notes": "The slide highlights safety data (CRS and ICANS) and toxicity management interventions.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/36",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-36",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 37,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "NXC-201 is highlighted with an orange border to emphasize its specific regimen.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/37",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-37",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 38,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "The table compares clinical trial inclusion criteria across four different therapies for relapsed/refractory multiple myeloma.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/38",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-38",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 39,
      "slideType": "comparison_table",
      "function": "compare_peers",
      "notes": "Highlights NXC-201's competitive advantage regarding prior BCMA therapy exclusion.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/39",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-39",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 40,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "The slide uses a numbered process flow layout.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/40",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-40",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 41,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses cross-trial comparison; disclaimer notes these are not head-to-head results.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/41",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-41",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 42,
      "slideType": "other",
      "function": "present_solution",
      "notes": "Includes a scientific mechanism of action diagram at the bottom.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/42",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-42",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 43,
      "slideType": "market_sizing",
      "function": "size_opportunity",
      "notes": "The slide uses a segmented horizontal axis to compare two distinct market segments by revenue.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/43",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-43",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 44,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a hub-and-spoke style diagram to link the platform pillars to specific drug candidates.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/44",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-44",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 45,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Slide contains three distinct data charts and a summary of clinical trial plans.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/45",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-45",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 46,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes three distinct proof-of-concept data panels (penetration, biodistribution, apoptosis).",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/46",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-46",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 47,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes waterfall chart and longitudinal line charts for patient cohorts.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/47",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-47",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 48,
      "slideType": "problem_statement",
      "function": "frame_problem",
      "notes": "The slide uses a bubble chart to show clinical trial outcomes and a table to detail efficacy/safety metrics across treatment lines.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/48",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-48",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 49,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "The slide uses a combination of a conceptual chart and a data table to demonstrate efficacy and safety in heavily pre-treated patients.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/49",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-49",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 50,
      "slideType": "traction",
      "function": "show_traction",
      "notes": "Includes survival curves, bioluminescence imaging of mice, and tumor frequency metrics.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/50",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-50",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 51,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a standard biological signaling pathway map to demonstrate the mechanism of action of the drug candidate.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/51",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-51",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 52,
      "slideType": "roadmap",
      "function": "plan_implementation",
      "notes": "Includes logos for BeiGene and Novartis.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/52",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-52",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 53,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "Includes a comparison of iMX-111 size vs IgG antibody, GLUT1 expression across tissues, correlation with cancer stage, and a survival curve.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/53",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-53",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 54,
      "slideType": "solution",
      "function": "present_solution",
      "notes": "The slide uses a combination of mechanism diagrams, clinical trial bar charts, and preclinical mouse model data to validate the therapeutic approach.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/54",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-54",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    },
    {
      "docId": "019de077-0cc2-77db-9351-9943b4f00de7",
      "docSlug": "7bc984921da16d0e07defb66ba0ce0a1",
      "documentTitle": "Immix Biopharma | Investor Presentation Deck | 56 slides",
      "authorId": "immix-biopharma",
      "authorName": "Immix Biopharma",
      "documentKindSlug": "pitchdeck",
      "documentKindLabel": "Pitch deck",
      "sourceTypeSlug": "investor_relations",
      "sourceTypeLabel": "Investor relations",
      "presentationDate": "2024-03-01 00:00:00",
      "orientation": "landscape",
      "aspectRatio": 1.7777778,
      "pageNumber": 55,
      "slideType": "competitive_analysis",
      "function": "compare_peers",
      "notes": "The slide uses a bar chart comparison to establish a benchmark for clinical efficacy in the IBD market.",
      "imagePath": null,
      "matchCount": 1,
      "evidence": null,
      "slideHref": "/slides/019de077-0cc2-77db-9351-9943b4f00de7/55",
      "deckHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7",
      "deckAnchorHref": "/decks/019de077-0cc2-77db-9351-9943b4f00de7#slide-55",
      "loopMatches": [],
      "arcBeatMatches": [],
      "imagePathAlt": null,
      "thumbSrc": null,
      "thumbSrcAlt": null,
      "locked": true
    }
  ]
}